Phase II Study of Adjuvant Chemotherapy With Gemcitabine and Nafamostat Mesilate for Pancreatic Cancer. Uwagawa T, Sakamoto T, Yasuda J, Shiozaki H, et al. Pancreas 2021;50:313-316.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Uwagawa T, Sakamoto T, Yasuda J, Shiozaki H, et al. Phase II Study of Adjuvant Chemotherapy With Gemcitabine and Nafamostat Mesilate for Pancreatic Cancer. Pancreas 2021;50:313-316.
PMID: 33835961